SCHEMBL7490977

SCHEMBL7490977

O=C(O)COc1cccc(CC2=C(c3nc(-c4ccccc4)c(-c4ccccc4)o3)C3CCC2C3)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP4 P15090 3/20 0.58
KDM4E B2RXH2 1/20 0.55
MEN1 O00255 1/20 0.55
ALDH1A1 P00352 1/20 0.55
CYP1A2 P05177 1/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2D6 P10635 1/20 0.55
HPGD P15428 1/20 0.55
KMT2A Q03164 1/20 0.55
HSD17B10 Q99714 1/20 0.55
PTGIR P43119 13/20 0.55
PTGER4 P35408 5/20 0.53
PTGER3 P43115 2/20 0.53
TBXA2R P21731 1/20 0.45
PTGER2 P43116 1/20 0.45
PTGDR Q13258 1/20 0.45
PTGER1 P34995 1/20 0.43
FABP3 P05413 1/20 0.39
PLA2G10 O15496 1/20 0.39
PLA2G2A P14555 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7488781 0.90 PTGIR (0.52) FABP4KDM4EMEN1ALDH1A1CYP1A2
SCHEMBL7493731 0.86 PTGIR (0.44) FABP4KDM4EMEN1ALDH1A1CYP1A2
SCHEMBL7960373 0.84 PTGIR (0.59) FABP4KDM4EMEN1ALDH1A1CYP1A2
SCHEMBL7957475 0.83 PTGIR (0.43) FABP4KDM4EMEN1ALDH1A1CYP1A2
SCHEMBL7949757 0.83 PTGIR (0.51) FABP4KDM4EMEN1ALDH1A1CYP1A2
SCHEMBL7949669 0.82 PTGIR (0.49) FABP4KDM4EMEN1HPGDKMT2A
SCHEMBL7959804 0.80 PTGER4 (0.48) FABP4KDM4ECYP3A4HPGDPTGIR
SCHEMBL8055514 0.79 PTGIR (0.84) FABP4KDM4EMEN1ALDH1A1CYP1A2
SCHEMBL8065459 0.78 FABP4 (0.56) FABP4KDM4EMEN1ALDH1A1CYP1A2
SCHEMBL6613103 0.78 PTGIR (0.85) FABP4KDM4EMEN1ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1213285-A2 4,5-dipheny-oxazole derivatives and their use as platelet aggregation inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-06-12 EP disclosed
US-6300344-B1 FOR THERAPEUTIC AND/OR PROPHYLACTIC TREATMENT OF ARTERIAL OBSTRUCTION, CEREBROVASCULAR DISEASE, HEPATIC CIRRHOSIS, ARTERIOSCLEROSIS, ISCHEMIC HEART DISEASE, RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY, HYPERTENSION FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-10-09 US disclosed
US-5972965-A USEFUL FOR INHIBITION OF PLATELET AGGREGATION, VASODILATION, ANTIHYPERTENSIVE ACTIVITY AND PROSTAGLANDIN AGONIST FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-10-26 US disclosed
EP-0842161-A1 4,5-DIARYL OXAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-05-20 EP disclosed
WO-1997003973-A1 4,5-DIARYL OXAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-02-06 WO disclosed